Peripheral and central mechanisms of stress resilience  by Pfau, Madeline L. & Russo, Scott J.
lable at ScienceDirect
Neurobiology of Stress 1 (2015) 66e79Contents lists avaiNeurobiology of Stress
journal homepage: http : / /www.journals .e lsevier .com/neurobiology-of-stress/Peripheral and central mechanisms of stress resilience
Madeline L. Pfau a, b, Scott J. Russo a, b, *
a Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029,
USA
b Graduate Program in Neuroscience, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USAa r t i c l e i n f o
Article history:
Received 5 August 2014
Received in revised form
19 September 2014
Accepted 22 September 2014
Available online 30 September 2014
Keywords:
Resilience
Stress
Depression
Anxiety
Neuroimmune
PlasticityAbbreviations: CUS, chronic unpredictable stress;
able stress; CSDS, chronic social defeat stress; LH, lea
and grooming; OVX, ovariectomy; SDR, social disrupt
* Corresponding author: Fishberg Department of N
Institute, Icahn School of Medicine at Mount Sinai, 1
York, NY 10029, USA. Tel.: þ1 212 659 5917.
E-mail address: scott.russo@mssm.edu (S.J. Russo)
http://dx.doi.org/10.1016/j.ynstr.2014.09.004
2352-2895/© 2014 The Authors. Published by Elseviera b s t r a c t
Viable new treatments for depression and anxiety have been slow to emerge, likely owing to the complex
and incompletely understood etiology of these disorders. A budding area of research with great thera-
peutic promise involves the study of resilience, the adaptive maintenance of normal physiology and
behavior despite exposure to marked psychological stress. This phenomenon, documented in both
humans and animal models, involves coordinated biological mechanisms in numerous bodily systems,
both peripheral and central. In this review, we provide an overview of resilience mechanisms throughout
the body, discussing current research in animal models investigating the roles of the neuroendocrine,
immune, and central nervous systems in behavioral resilience to stress.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Decades of research on human stress resilience have followed its
initial description in at risk children in the 1970s (Masten, 2001).
Resilience is deﬁned as the adaptive maintenance of normal
physiology, development and behavior in the face of pronounced
stress and adversity. Human resilience literature contains countless
examples of adults and childrenwho, despitemarked psychological
stress, display minimal adverse changes in emotional wellbeing or
behavioral disturbances (Feder et al., 2009; Yehuda et al., 2006b;
Alim et al., 2008; Fredrickson et al., 2003; Bonanno, 2004).
Although it is tempting to attribute human resilience to the
possession of exceptional abilities and coping mechanisms, both
social and biological, most people do not develop anxiety and
depressionwhen faced with stress (Masten, 2001; Bonanno, 2004).
Resilience is a common outcome that more likely involves the
successful application of the body's adaptive stress response to
maintaining the status quo. The biological processes underlying
resilience are often collectively termed “allostasis” and constituteSCUS, subchronic unpredict-
rned helplessness; LG, licking
ion stress.
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Inc. This is an open access article uvariation in bodily systems that functions to maintain homeostasis
in response to a stressor (McEwen, 2002). In some cases, allostasis
is exaggerated or fails to cease along with the stressor, and mech-
anisms that were once protective can become pathological. This
phenomenondtermed “allostatic load”dcan potentially result in
physiological and psychological damage, including enhanced sus-
ceptibility to disorders such as depression and anxiety (McEwen,
2002; Charney, 2004).
Mechanisms of resilience are of great interest due to the serious
burdens imposed on patients and society by stress-related disor-
ders including anxiety and depression. One in six Americans will
develop Major Depressive Disorder (MDD) during their lifetime, a
particularly alarming statistic as only 30% of patients achieve
complete remission of symptoms following treatment with current
ﬁrst-line therapies, the monoamine-based antidepressants
(Krishnan and Nestler, 2008; Kessler et al., 2005). When not
adequately treated, MDD can become a chronic, recurrent condition
characterized by escalating disability (Moussavi et al., 2007).
Comprehensive knowledge of the etiology of depression is still
lacking. Understanding the adaptive, allostatic mechanisms that
protect most individuals against psychopathology can potentially
inform therapeutic development and treatment strategies for more
vulnerable individuals.
Depression and anxiety are increasingly considered to be
“whole body” illnesses involving the dysregulation of multiple
systems, both peripheral and central. Similarly, resilience likely
results from successful allostatic mechanisms in thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
M.L. Pfau, S.J. Russo / Neurobiology of Stress 1 (2015) 66e79 67hypothalamoepituitaryeadrenal (HPA) axis, autonomic nervous
system, immune system and the brain (McEwen, 2002). In this
review, we summarize recent research into the roles of the
neuroendocrine, immune and central nervous systems in resilience
to stress, focusing primarily on animal models. We describe both
active, compensatory mechanisms as well as passive mechanisms
in which the absence of a maladaptive stress response promotes
resilience. We present resilience as an integrated process by which
adaptive mechanisms in multiple systems promote psychological
resilience to stress.
2. Animal models for the study of stress vulnerability and
resilience
Research on human subjects has yielded important insights into
the roles of various neurotransmitters, neuropeptides and hor-
mones as well as genetic factors in the neurobiology of resilience
(for comprehensive reviews, see Charney, 2004; Russo et al., 2012).
For ethical and practical reasons, animal models are often
employed to examine the causative effects of stress on biological
processes in the brain and body. Resilience to stress has been
documented and characterized in animal models throughout the
lifespan. Below, we describe in detail several behavioral paradigms
commonly used to elicit and study stress resilient phenotypes in
juvenile and adult animals.
2.1. Early life stress
Models of early life stress have informed our understanding of a
form of resilience called stress inoculation, whereby early stressful
experience attenuates stress response in adulthood. In children,
early stress can have a “steeling” effect, promoting subsequent
stress resistance and successful psychological functioning (Rutter,
2006). Animal models of early life stress typically involve expo-
sure to stressful stimuli during either the prenatal or postnatal
periods. Prenatal stressors include maternal stress such as gluco-
corticoid administration or food deprivation while early postnatal
stressors include brief bouts of maternal separation, altered
maternal care behavior, or glucocorticoid administration (Lupien
et al., 2009). Prolonged early life stress can cause programmed
HPA axis overactivity, altered glucocorticoid response, structural
changes in the brain, and deleterious effects on cognition, emotion
and behavior (Lupien et al., 2009). These effects can be reconciled
with the concept of stress inoculation by imagining adult outcomes
of early life stress as a U-shaped curvedanimals exposed to
moderate stress in early life show better outcomes and more
adaptive responses to stress in adulthood than do animals exposed
to minimal or severe stress (Macri et al., 2011). Stress inoculation
has been demonstrated in both primates and rodents. Infant
squirrel monkeys separated from their mothers for brief, inter-
mittent periods demonstrate reduced hormonal stress response in
subsequent developmental stages (Lyons et al., 2010; Parker et al.,
2005). They also demonstrate cognitive and emotional resilience
across measures relevant to anxiety and depression, such as
enhanced novelty tolerance, exploratory behavior and behavioral
response inhibition (Lyons et al., 2010; Parker et al., 2004, 2005).
There is a rich literature on stress inoculation in rodents demon-
strating that rats exposed to early life stress, including brief
maternal separations and neonatal corticosterone administration,
display blunted HPA axis response to stress in adulthood as well as
behavioral resilience in the form of reduced anxiety-like behavior
and enhanced performance in cognitive tasks (Macri et al., 2009;
Plotsky and Meaney, 1993; Macri and Wurbel, 2007; Levine,
1962; Levine et al., 1967). The relationship between early life
stress exposure and subsequent resilience in both primates androdents follows the abovementioned U-shaped curve. Prolonged
maternal separation and social isolation in infant rhesus monkeys
produce an increased stress response and “despair-like” behavior
in subsequent social separation tests (Young et al., 1973). Rats
exposed to moderate early life stress show enhanced measures of
resilience compared to both severely and minimally stressed rats
(Macri and Wurbel, 2007). For example, early postnatal rats
exposed to brief daily handling (a moderate stressor) subsequently
show attenuated stress response compared to undisturbed pups
and pups exposed to prolonged daily maternal separation (a more
severe stressor) (Plotsky and Meaney, 1993; Macri et al., 2004).
2.2. Chronic unpredictable stress
Chronic unpredictable stress (CUS) is a useful model for exam-
ining stress vulnerability and resilience in rodents (Ricon et al.,
2012; LaPlant et al., 2009). In CUS paradigms, animals are
exposed to varying mild stressors sequentially for a period of 1e7
weeks (Krishnan and Nestler, 2011; Willner, 1997). Stressors can
include mild foot shock, physical restraint, tail suspension, light/
dark cycle disruption, food or water restriction, changes to cage
mate, etc., and are changed after several hours to minimize habit-
uation (LaPlant et al., 2009; Willner, 1997). CUS produces a range of
depression and anxiety-like behaviors in rodents including anhe-
donia, measured as decreased sucrose preference, despair-like
behavior, measured as increased immobility in the forced swim
and tail suspension tests, and novelty suppressed feeding,
measured as a decrease in approach to a novel food item (Krishnan
and Nestler, 2011; Mineur et al., 2006; Feng et al., 2012). Mice
exposed to CUS also display decreased grooming, aggression, and
sexual behaviors. Certain CUS-induced behavioral changes, such as
novelty suppressed feeding, can be reversed only by chronic anti-
depressant treatment (Willner, 1997), making CUS relevant to hu-
man antidepressant responses. Female mice display immobility in
the forced swim test after just 6 days of subchronic unpredictable
stress (SCUS) whereas males are generally resilient to SCUS and
require 20e28 days of CUS exposure to elicit depression- and
anxiety-like behavior (Hodes, G.E. et al., Soc. Neurosci. Abstr. 219.01,
2011). Interestingly, age is a factor in response to CUSdmale rats
exposed to 60 days of CUS in the juvenile period exhibit greater
memory retention in a two-way shuttle avoidance task compared
to rats exposed to the same stressor in adulthood, indicating
enhanced cognitive resilience (Ricon et al., 2012). Sex differences
and age effects in susceptibility to CUS-induced depression and
anxiety-like behavior make this a powerful tool for investigating
the hormonal and neural basis for stress vulnerability and resil-
ience across the lifespan.
2.3. Chronic social defeat stress
Chronic social defeat stress (CSDS) is a prolonged social stress
paradigm used to delineate stress resilient and susceptible phe-
notypes in adult rodents. In the CSDS model, a C57BL/6J mouse is
repeatedly subordinated by a larger, aggressive CD-1 mouse for 10
consecutive days (Golden et al., 2011). Each physical bout is fol-
lowed by overnight sensory contact with the aggressor through a
plastic partition. Following CSDS, approximately 2/3 of experi-
mental mice, termed “susceptible,” develop a constellation of
depression-like behaviors including social avoidance and anhe-
donia (Krishnan et al., 2007; Donahue et al., 2014) as well as
metabolic syndrome marked by dysregulated feeding peptides,
weight gain and insulin insensitivity (Chuang et al., 2010; Lutter et
al., 2008). Conversely, the remaining 1/3 of mice, termed “resilient,”
develop a much milder phenotype, including elevated corticoste-
rone and increased anxiety-like behavior (Krishnan et al., 2007).
M.L. Pfau, S.J. Russo / Neurobiology of Stress 1 (2015) 66e7968Similar to human depression, CSDS-induced depression- and
anxiety-like behavior can be reversed by chronic, but not acute,
administration of antidepressants (Berton et al., 2006; Tsankova
et al., 2006). Importantly, a number of biomarkers identiﬁed in
humans with MDD are similarly disrupted in susceptible mice
following CSDS, further highlighting its utility in studying depres-
sion mechanisms (Krishnan et al., 2007; Golden et al., 2013;
Robison et al., 2014).
2.4. Learned helplessness
The learned helplessness (LH) model is an acute stress paradigm
that, similar to CSDS, produces heterogeneous responses, enabling
researchers to delineate stress susceptible and resilient animals
(Krishnan and Nestler, 2011). The proportion of animals exposed to
the LH paradigm that demonstrate phenotypic resilience ranges
from 10% to 80% (Cryan and Mombereau, 2004). In this model,
rodents are exposed to repeated inescapable foot shocks followed
by a test period in which an easy escape mechanism is made
available during shock exposure. Compared to control animals
trained with escapable shocks and resilient animals, susceptible
animals demonstrate “helplessness,” measured as longer escape
latency or failure to escape (Seligman and Beagley,1975). Like CSDS,
the LH paradigm produces numerous behavioral and physiological
changes including weight loss, HPA axis dysfunction, circadian al-
terations, and reductions in hippocampal synaptic spine number
(Krishnan and Nestler, 2011). A weakness of the model is that LH-
induced changes are short-lived, usually lasting only 2e3 days
and can be reversed with acute antidepressant treatment (Cryan
and Mombereau, 2004).
3. Neuroendocrine mechanisms of resilience
Appropriate response to stress involves the coordinated activity
of the autonomic nervous system (ANS) and the HPA axis as well as
the neural circuits in the hypothalamus, brainstem and forebrain
that control their activity (for a comprehensive review, see Ulrich-
Lai and Herman, 2009). Brieﬂy, stress induces ANS processes by ﬁrst
activating preganglionic sympathetic neurons in the spinal cord
that project to pre- or paravertebral ganglionic neurons. These
neurons terminate on cardiovascular and visceral organs or on the
adrenal medulla, and stimulate the release of adrenaline from the
adrenal medulla and noradrenaline from sympathetic nerve ﬁbers.
Consequences of ANS activation by stress include changes in heart
rate and vasoconstriction. In the HPA axis, stress activates neurons
in the paraventricular nucleus (PVN) of the hypothalamus to
secrete corticotropin releasing factor (CRF) and arginine vaso-
pressin (AVP) into the portal circulation via the median eminence,
which in turn stimulate the anterior pituitary gland to release ad-
renocorticotropic hormone (ACTH). ACTH activates glucocorticoid
synthesis and release from the adrenal cortex, which functions
primarily to mobilize energy stores during stress. There is ample
cross-talk between the ANS and the HPA axisdthe adrenal cortex
receives innervation from the sympathetic nervous system, regu-
lating glucocorticoid release, and glucocorticoids mediate ANS-
dependent stress responses including vasoconstriction. Modula-
tion of these systems has been noted in cases of human resilience to
MDD and post-traumatic stress disorder (PTSD), although results
have been largely correlative (Russo et al., 2012). High dose
glucocorticoid administration following traumatic stress exposure
has emerged as a potential treatment for individuals vulnerable to
PTSD, perhaps working by controlling hyperactive fear response
and fear memory consolidation (Kearns et al., 2012). This strategy
has yielded positive results in critically ill hospital patients and
combat-exposed veterans (Schelling et al., 2006; Suris et al., 2010).Additionally, dehydroepiandrosterone (DHEA) and neuropeptide Y
(NPY) have emerged as potential pro-resilience biomarkers in
humans. DHEA is released from the adrenal cortex with cortisol in
response to stress and can counter the effects of glucocorticoids
(Yehuda et al., 2006a). In combat-exposed veterans, both DHEA
level and DHEA/cortisol ratio correlate negatively with PTSD
symptom severity, suggesting that DHEA may serve a protective
role in situations of extreme stress. NPY is co-released with
noradrenaline from sympathetic nerves and has been shown to
correlate positively with interrogation performance and negatively
with dissociative symptoms in soldiers undergoing a U.S. Army
survival training course (Morgan et al., 2000b).
The Hypothalamic Pituitary Gonadal (HPG) axis shares
numerous component structures and neural circuitry with the HPA
axis, and accordingly, reproductive hormones serve a prominent
role in susceptibility and resilience to stress. Mood disorders
including MDD and anxiety are about two times more prevalent in
adultwomen thanmen, a sexdifference that emerges inpubertyand
persists until menopause, suggesting a role for sex hormone ﬂuc-
tuations and activating effects of gonadal hormones on neural cir-
cuitry (Deecher et al., 2008; Holden, 2005; Epperson et al., 2014).
Estrogen supports cognitive processes, inﬂuences catecholamine
and monoamine neurotransmission and metabolism, and regulates
the expression of transcription factors and neurotrophins
(Shanmugan and Epperson, 2014). Activation of brain stress
response and reward circuitry depends on menstrual cycle stage in
healthy adult women (Goldstein et al., 2010; Dreher et al., 2007).
Womenwith a history ofMDDdisplay hypoactivation of brain stress
response circuitry associated with lower serum estradiol levels and
higher serum progesterone levels compared to healthy controls
(Holsen et al., 2011). Mechanistically, perimenopause-associated
estradiol ﬂuctuations have been shown to contribute to vulnera-
bility in part by increasing brain levels of monoamine oxidase A
(MAO-A), an enzyme involved in apoptosis, oxidative stress, and
monoamine metabolism (Rekkas et al., 2014). Conversely, testos-
terone has emerged as a potential pro-resilience factor in men
(Russo et al., 2012). There is a strong positive correlation between
testosterone and degree of social connectedness, feelings of per-
sonal success, and social dominance (Edwards et al., 2006). Given its
role in social behavior and positive mood, it is not surprising that
blood and saliva testosterone levels decrease following stress
(Morgan et al., 2000a) and that lowcirculating levels are often found
in individualswith PTSDorMDD (Mulchaheyet al., 2001; Pope et al.,
2003). Early studies in men suggest that testosterone may be
effective in alleviating treatment resistant depression and as an
adjunct to treatment with selective serotonin reuptake inhibitors
(Pope et al., 2003). Although much future work is needed, together
this work suggests that testosterone may serve as a pro-resilience
factor by promoting positive mood and social connectedness.
3.1. The HPA axis
Animal studies investigating the mechanistic underpinnings of
resilience related to the HPA axis largely focus on models of devel-
opmental stress. Adult rats that have undergone stress inoculation
in the form of postnatal handling display lower basal levels of CRF,
blunted stress-induced increases in ACTH, CRF and corticosterone
secretion, and a more rapid post-stress recovery to basal stress
hormone levels compared to unstressed rats or those that have
undergone maternal separation (Plotsky and Meaney, 1993).
Meaney and Szyf (2005) have identiﬁedmaternal care behavior as a
mediator of early life stress resilience that produces long lasting
individual differences in gene expression and subsequent neuro-
endocrine stress response. In a study by Liu et al. (1997), they report
that mothers of handled rats displayed more licking, grooming and
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The amount and frequency of these maternal behaviors correlated
negatively with stress-induced plasma ACTH and corticosterone in
adulthood (Liu et al., 1997). This pro-resilient neuroendocrine stress
response in adult offspring of high maternal care mothers resulted
from increased hippocampal expression of glucocorticoid receptors
(GR), causing greater sensitivity to glucocorticoid negative feedback
on CRF and AVP. The group has since identiﬁed a number of mo-
lecular mediators of enhanced GR expression in handled pups such
as increased thyroid hormone secretion, serotonin turnover in the
hippocampus, and hippocampal expression of nerve growth factor-
inducible protein A (NGFI-A), a cAMP-inducible transcription factor
that binds exon 17 of the GR promoter (Meaney and Szyf, 2005;
Meaney et al., 2000; Weaver et al., 2004). In adult rats, epigenetic
mechanisms maintain glucocorticoid receptor sensitivity in resil-
ient animals. The 50 CpG dinucleotide site of the NGFI-A consensus
sequence on GR is always methylated in offspring of low licking and
grooming (LG) mothers whereas it is associated with acetylated H3
in the offspring of high LG mothers (Meaney and Szyf, 2005).
Methylation of this site prevents the binding of NGFI-A to the GR
promoter whereas acetylation has the opposite effect. In sum, high
LG maternal care produces sustained epigenetic modiﬁcations that
induce enhanced glucocorticoid receptor expression, enhanced
sensitivity to glucocorticoid negative feedback, reduced hypotha-
lamic release of AVP and CRF, and ultimately attenuated HPA axis
response to subsequent stress (Kappeler and Meaney, 2010).
Although less is known about the HPA mechanisms underlying
resilience to adulthood stress, two recent studies identify pro-
resilience epigenetic modiﬁcations at the CRF gene in PVN neu-
rons and CRF gating of brain-derived neurotrophic factor (BDNF) in
the nucleus accumbens (NAc) as important mediators. Following
CSDS exposure, Elliott et al. (2010) reported increased CRF mRNA
expression in the PVN and decreased methylation at four CpG sites
in the CRF promoter in susceptible, but not resilient, mice. Viral-
mediated knockdown of CRF in the PVN after social defeat pro-
moted resilient behavior in the social interaction test, suggesting
that CRF promoter methylation in resilient animals underlies
adaptive neuroendocrine and behavioral responses. Walsh et al.
(2014) found that optogenetic induction of phasic ﬁring in dopa-
minergic neurons of the ventral tegmental area (VTA) promoted
social avoidance behavior in mice following subthreshold social
defeat stress, an effect dependent upon CRF-gated induction of
BDNF in the NAc, a structure in which VTA dopaminergic pro-
jections terminate. As CRF antagonist infusion blocked the effects of
phasic stimulation on social avoidance behavior, CRF is likely an
essential mediator of vulnerability and resilience to defeat stress.
Future investigation of individual differences in CRF in the NAc will
further elucidate CRF activity in resilient animals.
3.2. Gonadal sex hormones
The effects of sex hormones on resilience and vulnerability to
stress are highly complicated and dependent upon the timing of
stress (adulthood vs. developmental) and behavioral domain
(cognitive vs. emotional resilience) (see Table 1). Adult female an-
imals tend to show greater cognitive resilience to chronic stress
than males, while males display enhanced emotional resilience.
Following chronic restraint stress, male rats exhibit deﬁcits in
hippocampal-dependent memory tasks including the radial arm
maze, object recognition test, Y maze, Morris water maze and ob-
ject location task, whereas female rats are either unaffected or
perform better on spatial and visual memory tasks (Luine, 2002;
Conrad et al., 2003; Kitraki et al., 2004). Mechanisms underlying
these differences in cognitive resilience include sex differences in
stress-induced changes to hippocampal morphology andcorticosteroid receptor sensitivity. Chronic restraint stress induces
atrophy of apical dendrites, measured as reduced dendritic length
and branch points, in the CA3 region of the hippocampus in male,
but not female, rats (Galea et al., 1997). Following 21 days of re-
straint stress, Kitraki et al. (2004) reported reduced GR immuno-
reactivity in the male rat hippocampus and impaired spatial
learning and memory in the Morris water maze. In contrast, hip-
pocampal GR and mineralocorticoid receptor immunoreactivity
were enhanced in stressed females.
Our laboratoryhas identiﬁednuclear factor kB (NFkB) signaling as
a potential mediator of emotional resilience to CUS (LaPlant et al.,
2009). NFkB is a transcription factor that, although most commonly
associated with immune function, can also be activated by stress
(Christoffel et al., 2011a). The activation and nuclear translocation of
NFkB is regulated by the IkB kinase complex (IkK),which triggers the
degradation of the cytoplasmic inhibitor of NFkB, IkB (Mohamed and
McFadden, 2009). As mentioned earlier, gonadally intact females
display depression-like behavior after SCUS, whereas males do not
exhibit emotional dysregulation at this time point. Ovariectomy
(OVX) abolished this enhanced behavioral susceptibility and blunted
transcriptional response to stressd170 genes were regulated by
SCUS in OVX mice vs. 619 in gonadally intact females, and many
overlapping genes were regulated in opposite directions. Viral
overexpression of IkK (signiﬁcantly upregulated in OVX mice) pre-
vented SCUS-induced immobility in the forced swim test in gona-
dally intact female mice, whereas overexpression of a dominant
negative form of IkK increased immobility in OVX mice. These ﬁnd-
ings suggest that IkKeNFkB signaling is necessary and sufﬁcient for
the expression of resilience following SCUS in females. Additional
ﬁndings suggest a role for DNA methyltransferase 3a (Dnmt3a) in
enhanced male emotional resilience to SCUS. RNA sequencing anal-
ysis revealed that female mice exhibit higher expression of Dnmt3a
mRNA than do males at baseline. Genetic deletion of Dnmt3a shifts
female transcriptional proﬁles following SCUS exposure toward a
more male-like pattern and promotes behavioral resilience to SCUS,
whereas viral overexpression of Dnmt3a promotes vulnerability to
SCUS. We consistently ﬁnd that the SCUS-induced transcriptional
proﬁles ofmale and femalemiceoverlapminimally (Hodes,G.E. et al.,
Soc. Neurosci. Abstr. 219.01, 2011; Pfau, M.L. et al., Soc. Neurosci. Abstr.
541.26, 2013). Furtherminingof these data setsmay reveal promising
patterns and candidate genes for further understanding of sex-
dependent stress resilience.
In addition to the activating effects of sex hormones on stress
circuitry in adulthood, prenatal perturbations can exert organiza-
tional effects on the brain that dictate sex differences in adult stress
response. Mueller and Bale (2008) reported increased depression-
like behavior in male, but not female, mice whose mothers had
been exposed to CUS during early pregnancy. Male mice displayed
elevated amygdala CRF expression and decreased hippocampal GR
expression that corresponded with epigenetic alter-
ationsdreduced methylation of the CRF promoter and enhanced
methylation of the 17 exon of the GR promoter. The authors iden-
tiﬁed sex differences in prenatal stress-induced placental gene
expression proﬁles, particularly differences in the methylation
maintenance enzyme Dnmt1, as potential developmental mecha-
nisms underlying adult phenotypes. Moreover, a recent study
showed that stress-induced pro-inﬂammatory placental gene
expression contributes to enhanced male susceptibility to prenatal
stress (Bronson and Bale, 2014). Maternal nonsteroidal anti-
inﬂammatory drug treatment reversed the stress-induced in-
crease in placental Interleukin 6 (IL-6) expression and ameliorated
locomotor hyperactivity (a behavioral indicator of dopaminergic
dysfunction) in prenatally stressed adult male mice. While much
work has focused on the maternal environment, an interesting
study by Rodgers et al. (2013) demonstrated a role for paternal
Table 1
Sexual dimorphism in rodent behavioral response to stress.
Stress paradigm Age Duration of stress Male behavioral phenotype Female behavioral phenotype
Paternal stress Sires were exposed to stress
one month prior to breeding
(Dietz et al., 2011)
10 Days of CSDS (Dietz et al.,
2011)
 Social avoidance (Dietz et al., 2011)
 Anxiety-like behavior (Dietz et al.,
2011)
 Increased locomotion in response to
novelty (Dietz et al., 2011)
 Decreased sucrose preference (Dietz
et al., 2011)
 Increased immobility in the Forced
Swim Test (FST) (Dietz et al., 2011)
 Anxiety-like behavior (Dietz
et al., 2011)
 Increased immobility in the
FST (Dietz et al., 2011)
Gestational stress Dams were exposed to the
stressor during early gestation
(days 1e7) (Mueller and Bale,
2007, 2008; Bronson and Bale,
2014)
7 Days of chronic variable stress
(Mueller and Bale, 2007; 2008;
Bronson and Bale, 2014)
 Impaired memory acquisition,
enhanced recall in the Barnes maze
(Mueller and Bale, 2007)
 Increased immobility in the Tail Sus-
pension Test (TST) and FST (Mueller
and Bale, 2008)
 Decreased sucrose preference
(Mueller and Bale, 2008)
 Locomotor hyperactivity (Bronson
and Bale, 2014)
 Enhanced memory acquisi-
tion in the Barnes maze
(Mueller and Bale, 2007)
Early life stress P2eP10 (Macri et al., 2009)
P1eP13 (Macri et al., 2004)
P1eP14 (Caldji et al., 2000)
Brief/mild: 9 days of low
corticosterone administration
to lactating mother (Macri et al.,
2009), 13 (Macri et al., 2004) or
14 (Caldji et al., 2000) days of
15-min maternal separation
Prolonged/severe: 9 days of
high corticosterone
administration to lactating
mother (Macri et al., 2009), 13
days of 4 h maternal separation
(Macri et al., 2004), 14 days of
3 h maternal separation (Caldji
et al., 2000)
Brief/mild:
 Enhanced attentional set-shifting
performance (cognitive ﬂexibility)
(Macri et al., 2009)
 Reduced latency to approach food
and water in a novel environment
(Macri et al., 2004; Caldji et al., 2000)
 Decreased startle response (Caldji
et al., 2000)
 Reduced anxiety-like behavior in the
open ﬁeld (Caldji et al., 2000)
Prolonged/severe:
 Similar in behavior to control animals
(Macri et al., 2004; Caldji et al., 2000)
 The effects of early life stress
are poorly understood in fe-
males, although recent evi-
dence suggests differential
effects of early life stress on
exploratory behavior, social
behavior and anhedonia
(Kundakovic et al., 2013)
Chronic restraint
stress
80 Days old (Kitraki et al., 2004)
2e3 Months old (Luine, 2002)
21 Days of 6 h restraint (Luine,
2002; Conrad et al., 2003;
Kitraki et al., 2004)
 Spatial and visual memory deﬁcits (Y
maze, Morris water maze, radial arm
maze, object recognition, object
location) (Luine, 2002; Conrad et al.,
2003; Kitraki et al., 2004)
 Normal or enhanced spatial
and visual memory (Luine,
2002; Conrad et al., 2003;
Kitraki et al., 2004)
Chronic social
defeat stress
7e8 Weeks old (Golden et al.,
2011; Krishnan et al., 2007;
Donahue et al., 2014)
10 Days of 10-min defeat bouts
(Golden et al., 2011; Krishnan
et al., 2007; Donahue et al.,
2014)
 “Susceptible” animals display social
avoidance, increased anxiety-like
behavior and decreased sucrose
preference (anhedonia) (Krishnan
et al., 2007; Donahue et al., 2014)
 “Resilient” animals display increased
anxiety-like behavior (Krishnan et al.,
2007)
 The CSDS model has not been
adequately adapted for use in
females due to a lack of
conspeciﬁc aggressive
behavior
Unpredictable stress Subchronic & Chronic: 7e8
weeks old (LaPlant et al., 2009;
Hodes, 2013)
Subchronic: 6 days of varied
1 h stressors (LaPlant et al.,
2009; Hodes, 2013)
Chronic: 21e28 days of varied
1 h stressors (Hodes, 2013)
Chronic:
 Decreased sucrose preference
(Hodes, 2013)
 Decreased grooming behavior
(Hodes, 2013)
 Increased latency to approach food in
a novel environment (Hodes, 2013)
 Increased immobility in the FST
(Hodes, 2013)
Subchronic & Chronic:
 Decreased sucrose prefer-
ence (Hodes, 2013)
 Decreased grooming
behavior (Hodes, 2013)
 Increased latency to
approach food in a novel
environment (Hodes, 2013)
 Increased immobility in the
FST (LaPlant et al., 2009;
Hodes, 2013)
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fathers exposed to CUS in puberty or adulthood displayed HPA axis
hypoactivity, which correlated with changes in paternal sperm
microRNA expression proﬁles. Together these results highlight the
complex interactions between genetics and environment in stress
resilience.
4. Immunity & resilience
The interaction of stress and the immune system has become a
major focus of psychiatric research since the introduction of the
“cytokine hypothesis of depression” in the 1990s (Maes et al.,2009). The hypothesis asserts that many of the central abnormal-
ities observed in depressiondenhanced HPA axis activity, neuro-
degeneration, decreased neurogenesis, oxidative stress, and
serotonergic signaling dysfunctiondare at least in part due to pe-
ripheral inﬂammatory cytokines released in response to external,
psychological stressors and internal stressors such as chronic dis-
ease and “leaky gut.”
A growing literature explores the connection between stress,
proinﬂammatory cytokines, and depression and anxiety-like
behavior in both humans and animals. Cytokines are soluble pro-
teins that are released at a site of infection by leukocytes. Upon
release, they can readily cross the bloodebrain barrier and act
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Sickness behaviors due to inﬂammation, such as social withdrawal
and disinterest in food, overlap greatly with depression behaviors
but are attenuated when infection is cleared (Dantzer et al., 2008).
Altered regulation of this adaptive behavioral response to immune
challenge by chronic illness or psychosocial stress contributes to
depression (Maes et al., 2009; Dantzer et al., 2008). For example,
patients with chronic inﬂammatory diseases such as multiple
sclerosis, rheumatoid arthritis and asthma can be up to 6 times
more likely to develop depression than healthy individuals
(Moussavi et al., 2007). Depressed patients also show markers of
inﬂammation, including elevated levels of cytokines and their sol-
uble receptors in serum and cerebrospinal ﬂuid, the most consis-
tently elevated being IL-6 (Maes et al., 1997; Dowlati et al., 2010).
Inﬂammatory markers are also elevated in rodent stress mod-
elsdchronic stress causes an elevation in serum and brain cyto-
kines including IL-6 and Interleukin-1b (IL-1b) (Sukoff Rizzo et al.,
2012; Voorhees et al., 2013; Koo and Duman, 2008). In both
humans receiving immunotherapy and animal models of inﬂam-
mation, administration of pro-inﬂammatory cytokines produces
depression and anxiety-like behaviors (Bonaccorso et al., 2001,
2002; Anisman et al., 2002; Sakic et al., 2001). While some
studies have shown that antidepressant medications reduce pe-
ripheral inﬂammation (Kubera et al., 2001a,b), others suggest the
opposite (Hannestad et al., 2011; Maes et al., 2012), resulting in a
shift in drug development efforts that focus on the use of more
direct anti-inﬂammatory agents to promote resilience.
Recent studies form a growing body of evidence that supports
the existence of individual differences in inﬂammatory response to
stress and subsequent physiological and behavioral vulnerability.
Here, we will discuss peripheral markers characteristic of vulner-
ability and resilience to stress as well as central mechanisms that
contribute to inﬂammation-mediated behavioral outcomes.
4.1. Heightened peripheral inﬂammation as a predictor and
consequence of stress vulnerability and resilience
Several reports examine changes in immune cell localization
and reactivity driven by stress exposure in rodents. Many of these
studies utilize a social stress model similar to CSDS called social
disruption stress (SDR). SDR involves chronic disruption of estab-
lished social hierarchies in cages of male mice. Male cagemates
establish a social hierarchy such that one mouse is the dominant,
alpha male and the remaining males are codominant or subordi-
nate (Avitsur et al., 2009). Once a day for a total of six days, a novel,
dominant intruder mouse previously screened for aggressive
behavior is placed into the housing cage for a period ranging from
hours to overnight (Avitsur et al., 2001). The dominant intruder
repeatedly attacks and defeats the resident mice, eliciting sub-
missive behaviors. SDR has been shown to activate the HPA axis,
enhance proinﬂammatory cytokine release, drive an increase in
splenic and blood CD11bþ monocytes via inﬂux from the bone
marrow and stimulate glucocorticoid resistance in immune cells
(Avitsur et al., 2009; Engler et al., 2008).
Following SDR, splenic leukocytes from stressed mice release
more Tumor Necrosis Factor a (TNF-a) and IL-6 in response to
stimulationwith lipopolysaccharide (LPS), a bacterial endotoxin and
toll-like receptor 4 agonist, compared to leukocytes from control
mice, an effect that is driven both by increased number of leukocytes
as well as enhanced release from each leukocyte (Avitsur et al.,
2005). Enhanced cytokine release likely stems from the glucocorti-
coid resistance demonstrated by splenic macrophages and mono-
cytes post-SDR, and indicates dysregulation of negative feedback
mechanisms by which glucocorticoids and cytokines together self
regulate stress-induced hyperinﬂammation (Stark et al., 2001). SDR-induced glucocorticoid resistance in macrophages is at least partly
due to a cytokine-mediated failure of corticosterone to stimulate
nuclear translocation of glucocorticoid receptors and prevent NFkB-
induced proinﬂammatory transcription (Quan et al., 2003). Splenic
macrophage enrichment and glucocorticoid resistance is dependent
upon Interleukin-1 (IL-1)dmice lacking IL-1 receptor type 1 do not
display these phenotypes (Engler et al., 2008). Interestingly, Avitsur
et al. (2001) observed individual differences in macrophage gluco-
corticoid resistance based upon level of social subordination. Sub-
missive mice were more likely to develop splenocyte corticosterone
insensitivity following SDR than were control or dominant mice.
Glucocorticoid resistance correlated negatively with time spent in
social exploration and positively with time spent in submissive
postures. Level of social exploration prior to SDR exposure was
predictive of submissive behavior during the ﬁrst session of SDR,
suggesting that pre-existing differences in mouse behavior may
predict response to SDR. Collectively, these results imply that the
adaptivemechanism bywhich corticosterone represses the immune
system in response to stress is compromised in susceptible (sub-
missive) mice but maintained in resilient (dominant) mice. Further
study is required to determine whether active molecular and
cellular mechanisms maintain glucocorticoid sensitivity in resilient
mice following SDR exposure and, similar to subordinate behavior,
whether baseline differences in these mechanisms can predict ul-
timate behavioral response. As glucocorticoid resistance is a hall-
mark symptom of depression, further understanding of immune cell
resilience to glucocorticoid insensitivity may prove particularly ad-
vantageous for therapeutics.
Recent ﬁndings by Hodes et al. (in press) suggest that pre-
existing differences in IL-6 signaling from leukocytes also predict
behavioral response to CSDS. Prior to any stress, leukocytes from
peripheral blood of mice that ultimately became susceptible to
CSDS released more IL-6 in response to ex vivo immune challenge
with LPS. Pro-susceptible mice had higher numbers of circulating
leukocytes, and leukocyte number and IL-6 release correlated
negatively with social interaction ratio, indicating a predictive
relationship. Increased leukocyte number is likely driven by an
increase in blood CD11bþ monocytes, as signiﬁcant differences in
proportions of leukocyte subtypes between susceptible and resil-
ient mice were observed only in monocytes. Generation of chimeric
mice via transplantation of bone marrow hematopoietic progenitor
cells from a susceptible donor produced a robust social avoidance
phenotype compared to control bonemarrow chimeras. In contrast,
chimeras generated via transplantation of progenitors from an IL-
6/ donor demonstrated behavioral resilience to CSDS, behaving
similarly to IL-6/ mice and mice treated with an IL-6 antibody,
which binds and neutralizes IL-6 in the peripheral circulation.
These ﬁndings suggest that peripherally derived IL-6 drives sus-
ceptibility to CSDS, and that susceptible and resilient mice display
baseline differences in leukocyte number and responsiveness. The
mechanisms contributing to pre-existing differences in stress
responsive IL-6 release and circulating leukocyte number are under
investigation and will inform our understanding of immune regu-
lation in resilience. Experiments investigating whether peripheral
blood leukocytes of mice susceptible to CSDS, like splenic leuko-
cytes in mice exposed to SDR, display glucocorticoid resistance may
prove particularly fruitful.
As mentioned above, increased levels of CD11bþ monocytes in
blood and spleen are both a risk factor for susceptibility to CSDS and
a consequence of RSD in mice. A likely mechanism underlying this
increased number of monocytes/macrophages is direct sympa-
thetic nervous system innervation of bone marrow and control of
bonemarrow hematopoiesis via b-adrenergic signaling. Two recent
studies propose that stress promotes proliferation and egress of
immature, pro-inﬂammatory myeloid cells from the bone marrow.
Fig. 1. The interface of the immune and central nervous systems. Peripheral immune
cells and signals reach the CNS via two primary routes: the neural pathway and the
humoral pathway. (1) In the neural pathway, peripheral cytokines activate primary
afferent nerves, including the vagus nerve, which terminates in the nucleus of the
solitary tract (NTS) in the medulla oblongata. Second order neurons project to brain-
stem, hypothalamic and forebrain nuclei involved in behavioral stress response. (2) In
the humoral pathway, cytokine signals cross the bloodebrain barrier by transport,
diffusion, or trafﬁcking of immune cells. Cytokines in the peripheral circulation cross
via cytokine transporters (a) or by activation of cytokine receptors on endothelial cells
of the brain vasculature (b), leading to the production of prostaglandins E2 (PGE2),
lipophilic molecules that can easily diffuse throughout the brain. Chronic social stress
can also promote the recruitment of peripherally derived macrophages into the brain
parenchyma of reward regions including the amygdala and prefrontal cortex (c). Cy-
tokines produced locally by macrophage-like cells in the circumventricular organs and
choroid plexus cross the BBB by volume diffusion (d). Once within the CNS, peripheral
signals activate microglia that in turn produce pro-inﬂammatory cytokines.
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RSD, stress induces a transcriptional pattern that ultimately leads to
myelopoiesis favoring immature, proinﬂammatory monocytes and
granulocytes that express high and intermediate levels, respec-
tively, of the surface marker Ly6c. RSD results in a 4-fold higher
prevalence of monocytes in blood and spleen as well as a 50e70%
increase in monocytic and granulocytic bone marrow progenitor
cells. Post-RSD genome-wide analysis of the peripheral blood
mononuclear cell transcriptome revealed a transcriptional mech-
anism underlying this phenomenondenhanced expression of
proinﬂammatory genes and genes related to myeloid cell lineage
commitment accompanied by decreased expression of genes
related to terminal myeloid differentiation. This transcriptional
pattern was dependent upon b-adrenergic signaling as adminis-
tration of propranolol, a b-adrenergic antagonist, prevented pro-
inﬂammatory transcription in peripheral blood monocytes as well
as the RSD-induced increase in Ly6chigh monocytes. A transcrip-
tional proﬁle favoring pro-inﬂammatory monocytes and b-adren-
ergic signaling was also identiﬁed in human subjects of low
socioeconomic status, a form of chronic social stress. Further, Heidt
et al. (2014) found that chronic variable stress increases numbers of
monocytes and neutrophils in mouse blood and bone marrow due
to proliferation of leukocyte progenitors. Stress-enhanced he-
matopoietic activity was accompanied by increased bone marrow
noradrenaline levels and decreased expression of CXCL12, a nega-
tive regulator of hematopoietic stem and progenitor cell (HSPC)
proliferation and migration that is in turn regulated by the b3-
adrenergic receptor. Treatment of stressed mice with a b3-adren-
ergic receptor antagonist increased CXCL12 expression, reduced
HSPC proliferation and attenuated the stress-induced increase in
circulating neutrophils and Ly6chigh monocytes. Together, these
studies provide compelling evidence in both humans and mice
linking stress vulnerability to sympathetic nervous system medi-
ated leukocytosis. Potentially informative future studies include an
investigation of leukocyte population shifts and transcriptional
proﬁles in blood and bone marrow of stress resilient subjects.
Many of the peripheral ﬁndings we've discussed focus primarily
on stress susceptible animals and suggest immune mechanisms of
passive resiliencedresilient and control animals lack peripheral
markers that are present and detrimental in susceptible animals.
However, as research in the ﬁeld shifts to focus more on pre-
existing individual differences in inﬂammation as a proxy for
vulnerability and resilience to depression and anxiety, we antici-
pate elucidation of active immune mechanisms of resilience, an
exciting prospect due to the relative feasibility of therapeutically
targeting peripheral systems with monoclonal antibodies, thus
reducing off-target effects in the central nervous system.
4.2. Central immune regulation of physiology and behavior
Peripheral cytokine signals reach the central nervous system via
two main pathwaysdstimulation of the vagal nerves and brain-
stem nuclei (the neural pathway) and crossing of the bloodebrain
barrier (the humoral pathway, see Fig. 1) (Dantzer et al., 2008;
Wohleb et al., 2013; Pavlov and Tracey, 2012; Quan, 2008). Cen-
trally derived cytokine signals are produced by microglia, resident
brain macrophages. Within the brain, inﬂammatory signals can
inﬂuence behavior through mechanisms including activation of the
HPA axis and glucocorticoid-induced neuronal atrophy (Iwata et al.,
2013) as well as excitatory synaptic plasticity (see Fig. 2) (Christoffel
et al., 2011a; Boersma et al., 2011).
Numerous studies investigating central stress-induced inﬂam-
matory processes have revealed a prominent role for IL-1b. Iwata
et al. (2013) propose that stress induces IL-1b release in the brain
primarily via the microglial NLRP3 inﬂammasome. NLRP3 is acytosolic pattern recognition receptor (PRR) that, when stimulated
by toll-like receptor 4 (TLR4) activation or ATP, both of which are
regulated by stress, binds to pro-caspase-1, forming the inﬂam-
masome complex. Pro-caspase-1 is cleaved and in turn cleaves
pro-IL-1b into IL-1b, which is then released from the cell. Microglia
constitutively express the components of the NLRP3 inﬂamma-
some, and acute restraint stress activates the NLRP3 inﬂamma-
some in the hippocampus, the brain region containing the highest
concentration of microglia and IL-1b receptors (Iwata et al., 2013;
Farrar et al., 1987). Intracerebroventricular (i.c.v) administration
of IL-1 results in increased anxiety-like behavior in the elevated
plus maze and open ﬁeld as well as spatial memory deﬁcits in the
Morris water maze (Song et al., 2006). In contrast, pharmacologic
or genetic inhibition of Interleukin-1 Receptor 1 (IL-1R1) blocks
anhedonia in rats exposed to CUS (Koo and Duman, 2008). Inter-
estingly, i.c.v administration of an IL-1R1 antagonist prevented
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inescapable tail shocks (Maier and Watkins, 1995). These results
suggest that IL-1b signaling is an important mediator of behavioral
vulnerability and resilience to LH and CUS in rats, and that IL-1b
and its downstream effectors may be promising targets for pro-
moting behavioral resilience to stress.
Downstream mechanisms by which IL-1b inﬂuences behavioral
outcomes to stress include HPA axis activation as well as modula-
tion of hippocampal neurogenesis. Stress-induced IL-1bmodulates
the HPA axis by stimulating release of CRF from the hypothalamus
and subsequent downstream release of ACTH from the pituitary
gland (Iwata et al., 2013; Sapolsky et al., 1987; Berkenbosch et al.,
1987). Blockade of IL-1R1 via antagonist administration or null
mutation prevents CUS-induced reductions in cells positive for
BrdU (Bromodeoxyuridine, a marker of cell division) and DCX
(doublecortin, a marker of immature neurons), indicating that
chronic stress inhibits neurogenesis in an IL-1b dependent fashion
(Koo and Duman, 2008). In the same study, in vitro incubation with
IL-1b decreased the proliferation of adult hippocampal progenitor
cells, an effect blocked by co-incubation with inhibitors of NFkB
signaling. As the IkKeNFkB signaling pathway is activated by IL-1b
and other pro-inﬂammatory cytokines, it is a promising candidate
mediator of the downstream effects of IL-1b. A follow-up study
revealed that, indeed, exposure to an acute stressor activated NFkB
signaling in neural stem-like cells (NSCs), and NFkB activation in
NSCs was dependent upon IL-1b signaling (Koo et al., 2010).
Moreover, i.c.v. administration of an NFkB inhibitor throughout CUS
blocked the subsequent stress-induced decrease in BrdUþDCXþ
cells as well as the expression of anxiety-like and anhedonic
behaviors.
Our lab has reported IkKeNFkB dependent structural and
functional plasticity in the mesolimbic dopaminergic reward
pathway following CSDS (Christoffel et al., 2011a). IkK and its
downstream targets IkB and phosphorylated IkB were upregu-
lated in the NAc of susceptible mice following CSDS. Interestingly,
activation of IkKeNFkB signaling promotes susceptibility to CSDS
by altering plasticity of glutamatergic synapses in the NAc. Stra-
tegies to blunt IkKeNFkB activation directly in NAc promote
resilience. A subsequent study revealed that constitutive viral
overexpression of IkK promotes baseline anxiety and depression-Fig. 2. Overview of immune activation in the peripheral and central nervous systems by st
immune events in peripheral systems. Sympathetic nerves release noradrenaline in the bon
release of immature, proinﬂammatory monocytes and neutrophils into the peripheral circ
themselves, trafﬁc to the brain by activating afferent nerves or by crossing the bloodebra
anxiety-like behavior by activating the HPA axis, the microglial NLRP3 inﬂammasome in thlike behaviors in the open ﬁeld and forced swim tests as well as
social avoidance and anhedonic behavior in response to an acute
social defeat stress (Christoffel et al., 2012). IkK expression
induced the formation of immature spines (primarily thin spines)
in mice exposed to acute social defeat stress. Again, spine density
correlated signiﬁcantly with social avoidance behavior, suggest-
ing that IkK-dependent, stress-induced morphological changes
may drive behavioral response to stress. Together, these data
suggest a critical role for IkKeNFkB signaling in NAc in suscep-
tibility vs. resilience to social stress. Future studies will be
important to identify the upstream inﬂammatory signaling
pathways responsible for such effects.
5. Molecular and cellular mechanisms of resilience in the
central nervous system
Much of our current knowledge regarding central mechanisms
of resilience centers on mesocorticolimbic reward circuitry. Brain
reward circuitry serves the adaptive purpose of focusing one's
attention on the acquisition of natural rewards to ultimately
ensure survival (Russo and Nestler, 2013). Mesocorticolimbic cir-
cuitry comprises neurons from the medial prefrontal cortex
(mPFC), hippocampus, NAc, amygdala, VTA, lateral hypothalamus,
and lateral habenula, among other brain regions (see Fig. 3).
Collectively, these brain regions are involved in numerous psy-
chological and cognitive processes that are impacted by stress and
compromised in patients with depression or anxiety (Christoffel
et al., 2011b). Connections between mesocorticolimbic regions
are dense and often complex. Here, we will focus primarily on the
most well characterized connections, those of the VTAeNAc
reward circuit. Dopaminergic neurons of the VTA project onto
GABAergic medium spiny neurons (MSNs) of the NAc, a structure
within the ventral striatum. VTA neurons release dopamine in
response to reward-related stimuli to initiate consumption and
sometimes also in response to aversive stimuli. The NAc sends
reciprocal connections back to the VTA via two pathwaysdthe
direct pathway, via D1-type MSNs; and the indirect pathway, via
D2-type MSNs, which innervate GABAergic interneurons in the
ventral pallidum that in turn synapse onto VTA neurons. Although
ﬁndings are variable, human imaging studies support a role forress. Chronic stress activates the sympathetic nervous system, precipitating a series of
e marrow hematopoietic stem cell (HSC) niche, stimulating myelopoiesis favoring the
ulation. Cytokine signals derived from these leukocytes and, in some cases, the cells
in barrier. Within the CNS, they produce lasting changes relevant to depression and
e hippocampus, and NFkBeIkK signaling in the ventral striatum.
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consistent reductions in NAc activity in adult patients as well as
NAc volume reductions in elderly patient populations (Husain
et al., 1991; Krishnan et al., 1992; Drevets et al., 1992; Mayberg
et al., 2000). Deep brain stimulation procedures targeting the
NAc and its efferent connections in the VTA have shown good
therapeutic efﬁcacy in treatment resistant depression (T.
Schlaepfer, personal communication). However, it is currently
unknown how these stimulation protocols affect NAc microcir-
cuitry and whether they indirectly stimulate ﬁbers of passages
that synapse outside the NAc.Fig. 3. Molecular and cellular mechanisms of resilience in the mesocorticolimbic reward c
matergic, GABAergic, and dopaminergic projections to and from the ventral tegmental ar
inhibitory connections mediated by interneurons. Hipp, hippocampus; mPFC, medial prefron
lateral dorsal tegmentum. (2) Shown are examples of processes that contribute to resilience
reduced Rac1 gene transcription characteristic of susceptible animals and attributed to re
(speciﬁed by M). In susceptible animals, reduced expression of Rac1 leads to actin cytoskel
DFosB activity promotes resilience by increasing expression of GluA2. Although shown here f
nucleus. GluA2-containing AMPA glutamate receptors are Ca2þ impermeable, reducing AMP
transmission has been associated with resilience, and optogenetic stimulation of ChR2 in t
stress-induced increase in dopaminergic phasic ﬁring that drives susceptibility. Increased ﬁ
homeostatically maintain normal ﬁring rate through the induction of Kþ channels. HAT, his
phosphorylation; TF, transcription factor.5.1. Epigenetic and transcriptional mechanisms
Numerous epigenetic and transcriptional mechanisms in mes-
ocorticolimbic reward circuitry underlie antidepressant action and
resilient behavioral responses to chronic stress. The transcription
factor DFosB is upregulated in the NAc of resilient mice following
CSDS in a serum response factor (SRF) dependent manner, and
genetic overexpression or antagonism of DFosB expression pro-
motes behavioral resilience or susceptibility, respectively (Vialou
et al., 2010a,b). Furthermore, DFosB levels are reduced in post-
mortem NAc samples of human depressed patients. Chronicircuitry. (1) A simpliﬁed schematic of the VTAeNAc circuit, showing the major gluta-
ea (VTA) and nucleus accumbens (NAc) in the rodent. Dashed lines indicate internal,
tal cortex; Amy, amygdala; LH, lateral habenula, RTMg, rostromedial tegmentum; LDTg,
vs. susceptibility to chronic social defeat stress. Within the NAc, resilient mice lack the
duced histone pan-acetylation (speciﬁed by A) and enhanced lysine 27 methylation
etal reorganization, and an increase in stubby, immature spines. Also in NAc neurons,
or simplicity in the synapse, DFosB is a transcription factor, and its activity occurs in the
A-mediated glutamate response and excitability. In the mPFC, increased glutamatergic
he mPFC has been shown to promote resilience. In the VTA, resilient animals lack the
ring in susceptible animals is driven by an increased cationic current. Resilient animals
tone acetyltransferase; HDAC, histone deacetylase; HMT, histone methyltransferase; P,
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NAc, and DFosB is required for ﬂuoxetine-mediated antidepressant
effects in susceptible mice. DFosB exerts its pro-resiliency effects
through its transcriptional targets, including AMPA glutamate re-
ceptor subunit GluA2 and Sparc-like 1 (SC1). Following CSDS,
resilient mice show greater NAc expression of GluA2 than do con-
trol or susceptible mice, an effect mediated by DFosB binding to the
GluA2 promoter. DFosB-mediated enhanced GluA2 expression
promotes resilience by decreasing AMPA functiondGluA2-
containing AMPA receptors are Ca2þ impermeable with lower re-
ceptor conductance and reduced inwardly rectifying currents. In
addition, SC1, a protein localized to the PSD and necessary for
proper synapse assembly, is upregulated both in mice over-
expressing DFosB and in mice resilient to CSDS. SC1 overexpression
reverses social avoidance behavior following CSDS.
Epigenetic regulation of ras-related C3 botulinum toxin substrate
1 (Rac1) has been shown by our laboratory to mediate susceptibility
vs. resilience to CSDS (Golden et al., 2013). Rac1 is a Rho GTPase
involved in the organization and maintenance of the actin cyto-
skeleton, largely through regulation of its downstream target coﬁlin,
an actin severing protein critically involved in synaptic plasticity.
Following CSDS, Rac1 was downregulated in the NAc of susceptible,
but not resilient, mice, and its expression correlated with social
avoidance behavior. Viral-mediated overexpression and knockdown
experiments demonstrated that Rac1 is necessary and sufﬁcient for
the expression of resilient behavior following CSDS. ChIP analysis of
permissive H3 acetylation (acH3) and repressive histone H3 Lys9
trimethylation (H3K9me3) at the Rac1 promoter and its upstream
regions revealed that, in both susceptible and resilient mice, Rac1
expression was mediated by epigenetic mechanisms. Susceptible,
but not resilient, mice exhibited reduced permissive acetylation at
the Rac1 promoter and its 2000-bp upstream region. Resilient mice
showed reduced methylation within the Rac1 promoter whereas
susceptible mice showed enhanced methylation in the 1000-bp
upstream region. Chronic intra-NAc administration of an HDAC in-
hibitor reversed social avoidance behavior and rescued Rac1
expression in susceptible mice. Collectively, these results suggest
that epigenetic mechanisms maintain Rac1 expression in resilient
mice, promoting adaptive behavioral response to stress, but have the
opposite effect in susceptible mice. Analysis of human postmortem
NAc tissue samples from depressed patients corroborated these
animal ﬁndings. Rac1 expression was strongly reduced in unmedi-
cated patients compared to controls, and depressed patients showed
decreased acetylation in regions ~200-bp upstream and down-
stream of the transcription start site (TSS) accompanied by increased
methylation in the gene region ~200-bp upstream of the TSS. Rac1
likely promotes resilient responses to CSDS via its effects on MSN
spine structure. Viral-mediated overexpression of Rac1 reduced the
CSDS-induced enhancement in dendritic stubby (immature) spine
density whereas Cre-mediated Rac1 genetic deletion had the
opposite effect.
5.2. Neurophysiology of susceptibility and resilience in the VTA
A robust neurophysiological correlate of susceptibility to CSDS is
the enhanced excitability of VTA dopamine neurons following
stress (Krishnan et al., 2008; Cao et al., 2010). CSDS increases the
spontaneous ﬁring rate of VTA dopamine neurons and the per-
centage of neurons demonstrating burst ﬁring events in suscepti-
ble, but not resilient, mice (Cao et al., 2010). These physiological
changes correlate inversely with social interaction score and can be
reversed with chronic antidepressant treatment, suggesting an
involvement of stress-induced changes to neuronal excitability in
depression-like behavior. One mechanism underlying enhanced
excitability in susceptible mice is the Ih (hyperpolarization-activated cation) current (Cao et al., 2010). The Ih current regulates
tonic ﬁring of dopamine neurons as well as the transition from
single-spike to burst ﬁring, and is robustly increased only in sus-
ceptible mice following CSDS. Ih inhibitor infusion reverses social
avoidance behavior, and chronic antidepressant treatment reduces
the stress-induced increase in Ih current. Enhanced neuronal
excitability is also mediated by reduced activation of AKT (thy-
moma-viral proto-oncogene) in the VTA, which likely produces a
subsequent reduction in inhibitory tone (Krishnan et al., 2008).
Phosphorylated AKT is reduced in the VTA of susceptible mice
following CSDS, and this reduction is necessary and sufﬁcient to
produce social avoidance behavior. AKT targets the b2 subunit of
the GABAA receptor, and in vitro pharmacological reduction of AKT
reduces the amplitude and frequency of spontaneous GABA-
mediated inhibitory postsynaptic currents (IPSCs) onto VTA dopa-
minergic neurons. Future in vivo studies are needed to causally link
AKT-GABA changes to social avoidance behavior. Recently,
Chaudhury et al. (2013) demonstrated that the CSDS-induced high
frequency phasic ﬁring in dopamine neurons of the VTAeNAc
pathway is sufﬁcient to functionally drive susceptible behavior.
Optogenetic induction of phasic, but not tonic, ﬁring in tyrosine
hydroxylase positive (THþ) VTA neurons during or after exposure
to subthreshold defeat rapidly produced robust social avoidance
and anhedonia behaviors. Induction of phasic ﬁring during the
social interaction test following 10 days of CSDS was sufﬁcient to
reverse behavior in mice previously identiﬁed as resilient, gener-
ating social avoidance, and to produce long-lasting changes in
excitability, as evidenced by maintenance of depression-like
behavior (decreased sucrose preference) 8e12 h post-stimulation.
These effects were VTAeNAc pathway speciﬁc, as selective opto-
genetic stimulation of VTA THþ neurons projecting to the PFC did
not induce social avoidance or anhedonia. Halorhodopsin inhibi-
tion of VTA ﬁring reversed depression-like behavior in susceptible
mice following CSDS exposure. These experiments demonstrate
that stress-induced phasic ﬁring in NAc-projecting VTA dopamine
neurons is necessary and sufﬁcient for the development of
depression-like behavior.
Normal dopamine neuron ﬁring rate, AKT activation and
signaling, and Ih current dynamics are allostatically preserved in
resilient mice during and after stress exposure, although the
mechanisms underlying this allostasis are less understood than
those driving susceptibility. A recent study by Friedman et al.
(2014) identiﬁed an active mechanism by which normal dopa-
mine neuron ﬁring is maintained in resilient mice. Surprisingly,
VTA dopamine neurons of resilient animals do not show a return to
a normal Ih current comparable to that of controls following CSDS.
Instead, they exhibit an Ih current increase that is much larger than
that of susceptible mice. Underlying this phenomenon is a ho-
meostatic enhancement in multiple Kþ channel currentsdthe
potentiated Ih current augments neuronal ﬁring to such an extent
that Kþ channels are activated, returning ﬁring rate to a normal
level. Indeed, current injection in dopamine neurons of resilient
mice produces a reduction in spike number, whereas current in-
jection produces the opposite effect in susceptible mice. Repeated
intra-VTA infusion of lamotrigine, an Ih potentiator, or VTA viral-
mediated overexpression of hyperpolarization-activated and cy-
clic nucleotide-gated channel 2 (HCN2), a channel that regulates Ih
current, reversed social avoidance and anhedonic behavior in sus-
ceptible mice. Bothmanipulations increased Ih and Kþ currents, and
reduced neuronal excitability. Further, repeated optogenetic in-
duction of hyperactivity in VTA dopamine neurons increased Kþ
currents and reversed social avoidance behavior. This type of ho-
meostatic plasticity was speciﬁc to VTAeNAc projecting neurons.
These ﬁndings provide exciting insight into the biology of resilience
as well as a potential therapeutic avenue.
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In addition to dopaminergic innervation from the VTA, the NAc
also receives glutamatergic innervation from the PFC, amygdala,
thalamus and hippocampus. Decreased PFC activity, as measured
by cerebral blood ﬂow and glucose metabolism, is the most robust
ﬁnding reported by human imaging studies of depressed patients
(Mayberg, 2009). Findings from rodent models are generally
consistent with those in humans and suggest that stress leads to
hypofrontal function. First, chronic stress leads to signiﬁcant at-
rophy and synapse loss on glutmatergic neurons in the PFC
(Christoffel et al., 2011b; McEwen and Morrison, 2013; Duman
and Li, 2012). Importantly, loss of synapses has also been
observed in the PFC of humans with MDD (Kang et al., 2012).
Covington et al. (2010) reported decreased expression of the im-
mediate early genes (IEGs) zif268 (also termed egr1) and arc in
human postmortem prefrontal cortical tissue of unmedicated
depressed patients. IEG expression was also reduced in the
ventromedial PFC of susceptible mice, but was unchanged in
resilient mice following CSDS. As IEG expression is considered a
representation of brain activity, these results suggest that activity
is reduced in susceptible mice and depressed patients, but
maintained in resilient mice. Optogenetic stimulation of the mPFC
of susceptible mice had an antidepressant effect, reversing social
avoidance and anhedonic behavior, and indicating that burst
ﬁring in mPFC neurons promotes behavioral resilience. Opto-
genetic induction of burst ﬁring also increased expression of the
IEG c-fos. The NAc is another region of brain reward circuitry that
undergoes signiﬁcant stress-induced remodeling of glutamatergic
synapses. Following CSDS, susceptible, but not resilient, mice have
an increased density of glutamatergic synapses on NAc MSNs,
which correlates with increased mini excitatory postsynaptic
potential (mEPSP) frequency (indicative of more functional glu-
tamatergic synapses or altered presynaptic release). Data from
our lab using circuit speciﬁc optogenetic tools to stimulate glu-
tamatergic neurons terminating in the ventral striatum (vStr),
ﬁnd that glutamatergic projections from the intralaminar thal-
amus (ILT) promote susceptibility to CSDS whereas stimulation of
projections from the PFC exert opposite effects (Christoffel, D.J.
et al., Soc. Neurosci. Abstr. 705.08, 2013). Both chronic, viral-
mediated expression in the ILT of tethered toxins (tToxins,
designed to inhibit excitatory transmission by selectively blocking
calcium inﬂux at the pre-synaptic voltage gated Ca2þ channels
Cav2.1 and Cav2.2) and rapid optogenetic inhibition of ILTevStr
terminal projections prevented social avoidance and reduced
MSN stubby spine density (a parameter that is known to posi-
tively correlate with social avoidance). Accordingly, rapid termi-
nal stimulation of ILT projections to the vStr was pro-susceptible,
inducing social avoidance in a subthreshold defeat. Together,
these ﬁndings suggest that ILTevStr projections are necessary and
sufﬁcient for the expression of social avoidance. In line with
previous work on the role of PFC activity in depression-like
behavior, chronic tToxin-mediated inhibition of PFC projections
was pro-susceptible. Surprisingly, the more speciﬁc, rapid opto-
genetic inhibition of PFCevStr glutamatergic terminals failed to
induce social avoidance. This indicates that PFC-mediated resil-
ience may require sustained activation of PFCeNAc terminals or
the activity of other PFC terminal projections outside the striatum.
While the PFC may provide a promising target for promoting
resilience to stress, further research is needed to fully elucidate
(1) the particular anatomical and physiological parameters of pro-
resilient PFC activity, and (2) whether allostatic mechanisms
maintain normal PFCevStr ﬁring patterns in resilient animals to
prevent pathological changes in reward circuit activity.6. Conclusion
With the exceptionof the rapidlyacting antidepressant ketamine
and the advent of deep brain stimulation paradigms to treat
depression, both of which are limited to severe, treatment resistant
cases of depression, there has been a decades long void of new
treatment options for depression and anxiety. However, the future
of treatment and research is hardly dire.Modern research on stress-
related disorders has yielded numerous potential targets and bio-
markers for diagnosis and treatment, largely due to an enhanced
focus on alternatives to monoamine-based mechanisms, such as
epigenetic mechanisms, immune-related factors, sex, and the
biology of resilience. Stress-related disorders, and resilience to
them, can be considered products of the coordinated activity of the
brain and numerous bodily systems. The results of resilience
research we've described here are particularly exciting as they offer
an opportunity for personalized science and medicine. We've
described potential targets and biomarkers speciﬁc to type of stress
(developmental vs. adulthood), sex, and inﬂammatory state. As
women are more likely to suffer from mood disorders, the
continuing identiﬁcation of sex-based, pro-resilience markers may
enable the development of more effective, sex speciﬁc treatments.
The NIH-mandated inclusion of female subjects in research studies
will hopefully encourage further elucidation of sex-based resilience.
We feel that immune mechanisms are particularly promising as
many potential targets are peripheral, removing the bloodebrain
barrier as a therapeutic obstacle. Preclinical experiments in our lab
indicate that peripherally targeting IL-6withmonoclonal antibodies
is antidepressant in mice (Hodes, G.E. et al., Soc. Neurosci. Abstr.
542.10, 2013). Further research on active mechanisms that maintain
normal immune function in resilient individuals, particularly the
maintenance of glucocorticoid sensitivity and normal leukocyte
differentiation and release from bonemarrow, may yield additional
therapeutic options for peripheral administration. An enhanced
focus throughout the ﬁeld on individual differences in response to
stress and inclusion of resilient animals as research subjects is
necessary, particularly in regard to studies of the immune system,
where study of stress-resilient subjects has been minimal. Further
interrogation of the mechanisms of what we've termed “passive”
resilience will also be helpful. As described in this review, the
adaptive failure of resilient animals to display the pathological
markers seen in susceptible animals is often accomplished by active
mechanisms. An enhanced focus on resilient subjectsmayenable us
to harness mechanisms of resilience in the body and brain for the
successful treatment of stress-related disorders.Acknowledgments
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